Mineralys Therapeutics Inc (MLYS)

Apr 15, 2026

David Malcom Rodman Sells 14,058 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock - MarketBeat

Apr 15, 2026

Apr 15, 2026

Mineralys CEO sells 15,730 shares under 10b5-1 plan | MLYS Insider Trading - Stock Titan

Apr 15, 2026

Apr 15, 2026

Congleton, Mineralys Therapeutics CEO, sells $421k in MLYS stock By Investing.com - Investing.com Canada

Apr 15, 2026

Apr 15, 2026

Mineralys Therapeutics (MLYS) CMO Rodman sold $548k in shares By Investing.com - Investing.com Canada

Apr 15, 2026

Apr 15, 2026

MLYS Stock Climbs As FDA Review And New CLO Draw Trader Focus - timothysykes.com

Apr 15, 2026

Apr 15, 2026

David Rodman sells shares; Mineralys Therapeutics (NASDAQ: MLYS) Form 144 listing - Stock Titan

Apr 15, 2026

Apr 13, 2026

Mineralys therapeutics MLYS: Chief medical officer sells $59k in shares - Investing.com India

Apr 13, 2026

Apr 13, 2026

Mineralys (MLYS) CMO exercises options and sells 2,170 shares under 10b5-1 plan - Stock Titan

Apr 13, 2026

Apr 13, 2026

Mineralys Therapeutics (NASDAQ: MLYS) insider sales and RSU vesting disclosed - Stock Titan

Apr 13, 2026

Apr 13, 2026

Affiliate sale of 14,058 shares and multiple David Rodman trades (MLYS) - Stock Titan

Apr 13, 2026

Apr 11, 2026

(MLYS) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

Apr 11, 2026

Apr 10, 2026

Sentiment Recap: Whats the profit margin of Mineralys Therapeutics Inc2026 Key Highlights & Daily Profit Maximizing Tips - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Aug Catalysts: What is Mineralys Therapeutics Incs revenue forecastQuarterly Portfolio Summary & Daily Oversold Bounce Ideas - baoquankhu1.vn

Apr 10, 2026

Apr 09, 2026

Retail Trends: What are the future prospects of Mineralys Therapeutics Inc2026 Sentiment & Community Shared Stock Ideas - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Mineralys Therapeutics (MLYS) Rule 144: Director sales and 2,170-share cashless exercise - Stock Titan

Apr 09, 2026

Apr 08, 2026

Form DEFA14A Mineralys Therapeutics, - StreetInsider

Apr 08, 2026

Apr 08, 2026

Mineralys Therapeutics (NASDAQ: MLYS) details 2026 virtual meeting, board elections - Stock Titan

Apr 08, 2026

Apr 08, 2026

Signal Recap: What are the future prospects of Mineralys Therapeutics Inc2026 Snapshot & Weekly High Return Stock Forecasts - baoquankhu1.vn

Apr 08, 2026

Apr 07, 2026

Does Mineralys Therapeutics’ (MLYS) FDA Progress and Legal Hire Reshape Its Cardiorenal Commercialization Strategy? - Yahoo Finance

Apr 07, 2026

Apr 07, 2026

Mineralys Therapeutics' CEO Sold Shares Worth $1.97 Million. Should Investors Avoid the Stock? - Yahoo Finance

Apr 07, 2026

Apr 06, 2026

Profit Recap: Is Mineralys Therapeutics Inc impacted by rising ratesQuarterly Growth Report & Low Drawdown Trading Techniques - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

Why Mineralys Therapeutics Stock Is Surging Today - TipRanks

Apr 06, 2026

Apr 06, 2026

Mineralys Therapeutics, Inc. (MLYS) stock price, news, quote and history - Yahoo Finance UK

Apr 06, 2026

Apr 06, 2026

Avalyn Appoints Biopharmaceutical Veteran to Board - National Today

Apr 06, 2026

Apr 06, 2026

Avalyn Appoints Jon Congleton To Board - citybiz

Apr 06, 2026

Apr 06, 2026

Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors - The Manila Times

Apr 06, 2026

Apr 05, 2026

Mineralys Therapeutics (MLYS) garnering attention with lorundrostat progress - MSN

Apr 05, 2026

Apr 05, 2026

Earnings Miss: Whats the RSI of Mineralys Therapeutics Inc stock2026 Levels & Capital Protection Trading Alerts - baoquankhu1.vn

Apr 05, 2026

Apr 03, 2026

Mineralys Therapeutics CEO Congleton sells $1.97 million in MLYS stock By Investing.com - Investing.com Australia

Apr 03, 2026

Apr 02, 2026

Insider Sell: CEO Jon Congleton Sells 75,000 Shares of Mineralys Therapeutics Inc (MLYS) - GuruFocus

Apr 02, 2026

Apr 02, 2026

Mineralys Therapeutics (NASDAQ:MLYS) CEO Jon Congleton Sells 75,000 Shares - MarketBeat

Apr 02, 2026

Apr 02, 2026

Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Director Sells 3,000 Shares of Stock - MarketBeat

Apr 02, 2026

Apr 02, 2026

Daphne Karydas, director at Mineralys, sells $75,000 in MLYS stock By Investing.com - Investing.com Australia

Apr 02, 2026

Apr 02, 2026

Daphne Karydas, director at Mineralys, sells $75,000 in MLYS stock - Investing.com

Apr 02, 2026

Apr 02, 2026

Mineralys Therapeutics CEO Congleton sells $1.97 million in MLYS stock - Investing.com

Apr 02, 2026

Apr 02, 2026

Mineralys (MLYS) CEO sells 75,000 shares, still holds 705k - Stock Titan

Apr 02, 2026

Apr 02, 2026

Mineralys Therapeutics (MLYS) director trades 3,000 shares under plan - Stock Titan

Apr 02, 2026

Apr 02, 2026

IPO Launch: How sensitive is Mineralys Therapeutics Inc to inflationMarket Rally & AI Enhanced Market Trend Forecasts - baoquankhu1.vn

Apr 02, 2026

Apr 02, 2026

Mineralys Therapeutics (NASDAQ:MLYS) Director Acquires $7,354,269.00 in Stock - MarketBeat

Apr 02, 2026

Apr 01, 2026

Analysts Offer Insights on Healthcare Companies: Inventiva (IVA), Neumora Therapeutics, Inc. (NMRA) and Gain Therapeutics (GANX) - theglobeandmail.com

Apr 01, 2026

Apr 01, 2026

Mineralys Therapeutics Surges on FDA Milestone Buzz - TipRanks

Apr 01, 2026

Apr 01, 2026

Mineralys Therapeutics (MLYS) Garnering Attention With Lorundrostat Progress - Insider Monkey

Apr 01, 2026

Apr 01, 2026

Mineralys Therapeutics(MLYS.US) Director Buys US$8.76 Million in Common Stock - 富途牛牛

Apr 01, 2026

Mar 31, 2026

Mineralys Therapeutics (NASDAQ: MLYS) insider sells 3,000 shares - Stock Titan

Mar 31, 2026

Mar 31, 2026

Mineralys Therapeutics (MLYS) files Form 144 to sell 75,000 shares - Stock Titan

Mar 31, 2026

Mar 31, 2026

RA Capital funds add 369,000 Mineralys (NASDAQ: MLYS) shares - Stock Titan

Mar 31, 2026

Mar 31, 2026

Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Up 12.4%What's Next? - MarketBeat

Mar 31, 2026

Mar 31, 2026

Investors Purchase High Volume of Mineralys Therapeutics Put Options (NASDAQ:MLYS) - marketbeat.com

Mar 31, 2026